KOL kliniske forsøg i Indiana
10 studier for KOL søger deltagere på steder i Indiana.
Byer i Indiana
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Valparaiso
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asha Clinical Research - Munster- Site Number : 8400115, Hammond
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research-Indianapolis, Indianapolis
RekruttererFase 2
Alder 40 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Indiana University Health University Hospital, Indianapolis
- IU Health Ball Memorial Hospital, Inc., Muncie
RekruttererFase 2
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Indy Clinical Research- Site Number : 8400071, Indianapolis
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evansville
- Research Site, Indianapolis
- Research Site, Indianapolis
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Munster
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
RekruttererObservationsstudie
Alder 40 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- ASHA Clinical Research - Munster, LLC, Hammond
- Methodist Hospital Southlake, Merrillville
RekruttererFase 2/3
Alder 35 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT07363694Acoustic Waveform Respiratory Evaluation
- Indiana University, Indianapolis
RekruttererFrivillige med god helbredstilstand velkomne
Alder 8 til 70 · Alle køn · Opdateret 24. okt. 2025 · NCT06512064Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.